Exchange: NYSE·Updated 06:05 PM EDT
ELV logo

ELVElevance Health Inc

$377.00
$0.42
(0.11%)
Today
Closed $376.40
$0.60
(0.16%)
After Hours
Reported EarningsJul 15
Mkt Cap$81.54B
Vol783,812.00
Latest Earnings Results: Q2 '26

Reported: Jul 15

Estimated EPS

$6.21

Reported EPS

$7.45

Surprise

+19.94%

Estimated Rev

$48.84B

Reported Rev

$49.83B

Surprise

+2.01%

$ELV Q2 '26 Earnings Results & Recap Elevance Health raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, while raising operating cash flow guidance to $6.0 billion.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$4.73
--
--
N/A
Q2 '26
$6.21
$7.45
19.94%
BEAT
Q1 '26
$11.03
$12.58
14.02%
BEAT
Q4 '25
$3.10
$3.33
7.54%
BEAT
Q3 '25
$4.93
$6.03
22.24%
BEAT

Advertisement|Remove ads.